Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 113,938 | 68,064 | 400,304 | 52,069 | 162,826 |
| Marketable Securities | 369,616 | 425,948 | 273,052 | 162,090 | N/A |
| Receivables | 23,412 | 215 | N/A | 3,577 | 3,414 |
| TOTAL | $516,786 | $499,787 | $685,505 | $220,425 | $170,416 |
| Non-Current Assets | |||||
| PPE Net | 38,361 | 29,627 | 24,363 | 6,188 | 6,661 |
| Investments And Advances | 64,406 | 0 | 0 | 54,059 | 0 |
| Other Non-Current Assets | 88,141 | 10,710 | 5,869 | 2,123 | 1,821 |
| TOTAL | $190,908 | $40,337 | $30,232 | $62,370 | $8,482 |
| Total Assets | $707,694 | $540,124 | $715,737 | $282,795 | $178,898 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 1,518 | 2,551 | 3,266 |
| Accounts payable and accrued liabilities | 4,793 | 3,298 | 3,744 | 2,211 | 2,455 |
| Accrued Expenses | 88,706 | 51,711 | 30,541 | 11,746 | 6,443 |
| TOTAL | $106,482 | $60,323 | $42,890 | $28,512 | $18,640 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 1,518 | 4,072 |
| Deferred Revenues | 6,160 | 3,600 | 5,373 | 11,426 | 5,898 |
| Other Non-Current Liabilities | 96,940 | 192 | 131 | 154 | 253 |
| TOTAL | $136,853 | $60,792 | $48,877 | $41,205 | $16,279 |
| Total Liabilities | $243,335 | $121,115 | $91,767 | $69,717 | $34,919 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 54,027 | 44,099 | 43,704 | 33,204 | 27,201 |
| Common Shares | 49 | 44 | 43 | 33 | 27 |
| Retained earnings | -945,238 | -597,545 | -355,589 | -207,470 | -134,975 |
| Other shareholders' equity | -2,535 | -180 | -269 | -18 | 0 |
| TOTAL | $464,359 | $419,009 | $623,970 | $213,078 | $143,979 |
| Total Liabilities And Equity | $707,694 | $540,124 | $715,737 | $282,795 | $178,898 |